Trial · NCT05094154
Results by group20
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 20
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Acute Kidney Injury (AKI) Ordinal Scale | Anti-pseudomonal Cephalosporin | 0 = Survived without AKI | 910 | Participants | |
| Acute Kidney Injury (AKI) Ordinal Scale | Anti-pseudomonal Penicillin | 0 = Survived without AKI | 952 | Participants | |
| Acute Kidney Injury (AKI) Ordinal Scale | Anti-pseudomonal Cephalosporin | 1 = Survived with Stage 1 AKI | 86 | Participants | |
| Acute Kidney Injury (AKI) Ordinal Scale | Anti-pseudomonal Penicillin | 1 = Survived with Stage 1 AKI | 100 | Participants | |
| Acute Kidney Injury (AKI) Ordinal Scale | Anti-pseudomonal Cephalosporin | 2 = Survived with Stage 2 AKI | 41 | Participants | |
| Acute Kidney Injury (AKI) Ordinal Scale | Anti-pseudomonal Penicillin | 2 = Survived with Stage 2 AKI | 70 | Participants | |
| Acute Kidney Injury (AKI) Ordinal Scale | Anti-pseudomonal Cephalosporin | 3 = Survived with Stage 3 AKI | 85 | Participants | |
| Acute Kidney Injury (AKI) Ordinal Scale | Anti-pseudomonal Penicillin | 3 = Survived with Stage 3 AKI | 97 | Participants | |
| Acute Kidney Injury (AKI) Ordinal Scale | Anti-pseudomonal Cephalosporin | 4 = Died | 92 | Participants | |
| Acute Kidney Injury (AKI) Ordinal Scale | Anti-pseudomonal Penicillin | 4 = Died | 78 | Participants | |
| Major Adverse Kidney Events Within 14 Days (MAKE14) | Anti-pseudomonal Cephalosporin | 124 | Participants | ||
| Major Adverse Kidney Events Within 14 Days (MAKE14) | Anti-pseudomonal Penicillin | 114 | Participants | ||
| Delirium and Coma-Free Days to Day 14 | Anti-pseudomonal Cephalosporin | 14 | Inter-Quartile Range 14 to 14 | days | |
| Delirium and Coma-Free Days to Day 14 | Anti-pseudomonal Penicillin | 14 | Inter-Quartile Range 14 to 14 | days | |
| Post-Emergency Department Disposition | Anti-pseudomonal Cephalosporin | Home | 26 | participants | |
| Post-Emergency Department Disposition | Anti-pseudomonal Penicillin | Home | 23 | participants | |
| Post-Emergency Department Disposition | Anti-pseudomonal Cephalosporin | Ward | 1016 | participants | |
| Post-Emergency Department Disposition | Anti-pseudomonal Penicillin | Ward | 1117 | participants | |
| Post-Emergency Department Disposition | Anti-pseudomonal Cephalosporin | ICU | 93 | participants | |
| Post-Emergency Department Disposition | Anti-pseudomonal Penicillin | ICU | 103 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05094154/results